Apremilast
Product Description
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD.
-
CN -
2015On CPHI since
-
4Certificates
-
5000+Employees
Company types
Primary activities
Categories
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD.
-
CN
-
2015On CPHI since
-
4Certificates
-
5000+Employees
Company types
Primary activities
More Products from ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (99)
-
Product Adenine Phosphate
ChPCN Status(A) -
Product Afoxolaner
Therapeutic Area: Parasite
Status: Validated -
Product Anastrozole
Oncology APIUSP, ChP+YBH
USDMF(Submitted), CN Status(A) -
Product Anidulafungin
Therapeutic Area:Infection
Status:Pilot
-
Product Apalutamide
Therapeutic Area:Oncology
Status:Pilot
-
Product Apixaban
Cardiovascular APIYBY
CN Status(A) -
Product Aripiprazole
USP, ChP+YBYUSDMF, CN Status(A) -
Product Ascomycin
In house
-
Product avacopan
Therapeutic Area: ANCA-Associated Vasculitis(AAV) ANCA
Status: Early
-
Product Baloxavir Marboxil
Therapeutic Area: Influenza
Status: Early
-
Product Bedaquiline Fumarate
Anti-infection APIIn house
CN Status(A) -
Product Belumosudil
Therapeutic Area: Immunology
Status: Early